Table 1 Characteristics of the studies identified in the systematic review
Reference | Year | Country | Study type | Study period | Participants | Intervention | Comparison |
|---|---|---|---|---|---|---|---|
Passos et al. | 2014 | Canada | Retrospective cohort study | 01/2001–12/2010 | 190 | PH tourniquet (n = 4) | No tourniquet (n = 186) |
Scerbo et al. | 2017 | US | Retrospective cohort study | 10/2008–01/2016 | 281 | PH tourniquet (n = 252) | Late tourniquet (n = 29) |
Teixeira et al. | 2018 | US | Retrospective cohort study | 01/2011–12/2016 | 1026 | PH tourniquet (n = 181) | No tourniquet (n = 845) |
Smith et al. | 2019 | US | Retrospective cohort study | 2010–2018 | 204 | PH commercial tourniquet application (n = 127) | No tourniquet (n = 77) |
McNickle et al. | 2019 | US | Retrospective cohort study | 01/2013–12/2017 | 138 | PH tourniquet (n = 69) | No tourniquet (n = 69) |
Henry et al. | 2021 | US | Retrospective cohort study | 10/2015–07/2019 | 944 | PH tourniquet (n = 97) | No tourniquet (n = 847) |
Schroll et al. | 2022 | US | Prospective cohort study | 2015–2020 | 1312 | PH improvised or commercial tourniquet application (n = 962) | No tourniquet + late tourniquet (n = 350) |